These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
832 related items for PubMed ID: 9530478
21. Renal effects of synthetic colloids and crystalloids in patients with severe sepsis: a prospective sequential comparison. Bayer O, Reinhart K, Sakr Y, Kabisch B, Kohl M, Riedemann NC, Bauer M, Settmacher U, Hekmat K, Hartog CS. Crit Care Med; 2011 Jun; 39(6):1335-42. PubMed ID: 21358396 [Abstract] [Full Text] [Related]
22. Effect of rapid fluid resuscitation using crystalloids or colloids on hemostasis in piglets. Mauch J, Madjdpour C, Kutter AP, Spielmann N, Bettschart-Wolfensberger R, Weiss M, Haas T. Paediatr Anaesth; 2013 Mar; 23(3):258-64. PubMed ID: 23279083 [Abstract] [Full Text] [Related]
23. [Effects of plasma substitutes on hemostasis]. Blanloeil Y, Trossaërt M, Rigal JC, Rozec B. Ann Fr Anesth Reanim; 2002 Oct; 21(8):648-67. PubMed ID: 12471786 [Abstract] [Full Text] [Related]
24. [Blood volume replacement and hemodilution with hydroxyethyl starch]. Messmer K, Jesch F. Infusionsther Klin Ernahr; 1978 Jun; 5(3):169-77. PubMed ID: 78893 [Abstract] [Full Text] [Related]
25. A total balanced volume replacement strategy using a new balanced hydoxyethyl starch preparation (6% HES 130/0.42) in patients undergoing major abdominal surgery. Boldt J, Schöllhorn T, Münchbach J, Pabsdorf M. Eur J Anaesthesiol; 2007 Mar; 24(3):267-75. PubMed ID: 17054812 [Abstract] [Full Text] [Related]
26. Human albumin and colloid fluid replacement: their use in general surgery. Camu F, Ivens D, Christiaens F. Acta Anaesthesiol Belg; 1995 Mar; 46(1):3-18. PubMed ID: 7618426 [Abstract] [Full Text] [Related]
27. A randomized clinical trial of 10% pentastarch (low molecular weight hydroxyethyl starch) versus 5% albumin for plasma volume expansion after cardiac operations. London MJ, Ho JS, Triedman JK, Verrier ED, Levin J, Merrick SH, Hanley FL, Browner WS, Mangano DT. J Thorac Cardiovasc Surg; 1989 May; 97(5):785-97. PubMed ID: 2468978 [Abstract] [Full Text] [Related]
28. Volume replacement therapy during major orthopedic surgery using Voluven (hydroxyethyl starch 130/0.4) or hetastarch. Gandhi SD, Weiskopf RB, Jungheinrich C, Koorn R, Miller D, Shangraw RE, Prough DS, Baus D, Bepperling F, Warltier DC. Anesthesiology; 2007 Jun; 106(6):1120-7. PubMed ID: 17525586 [Abstract] [Full Text] [Related]
29. Safety of HES 130/0.4 (Voluven(R)) in patients with preoperative renal dysfunction undergoing abdominal aortic surgery: a prospective, randomized, controlled, parallel-group multicentre trial. Godet G, Lehot JJ, Janvier G, Steib A, De Castro V, Coriat P. Eur J Anaesthesiol; 2008 Dec; 25(12):986-94. PubMed ID: 18492315 [Abstract] [Full Text] [Related]
30. Rapid restoration of microcirculatory blood flow with hyperviscous and hyperoncotic solutions lowers the transfusion trigger in resuscitation from hemorrhagic shock. Wettstein R, Erni D, Intaglietta M, Tsai AG. Shock; 2006 Jun; 25(6):641-6. PubMed ID: 16721273 [Abstract] [Full Text] [Related]
31. 3.5% urea-linked gelatin is as effective as 6% HES 200/0.5 for volume management in cardiac surgery patients. Van der Linden PJ, De Hert SG, Daper A, Trenchant A, Schmartz D, Defrance P, Kimbimbi P. Can J Anaesth; 2004 Mar; 51(3):236-41. PubMed ID: 15010405 [Abstract] [Full Text] [Related]
32. Six percent hydroxyethyl starch 130/0.4 (Voluven®) versus 5% human serum albumin for volume replacement therapy during elective open-heart surgery in pediatric patients. Van der Linden P, De Villé A, Hofer A, Heschl M, Gombotz H. Anesthesiology; 2013 Dec; 119(6):1296-309. PubMed ID: 23934169 [Abstract] [Full Text] [Related]
33. Short-term effectiveness of different volume replacement therapies in postoperative hypovolaemic patients. Gondos T, Marjanek Z, Ulakcsai Z, Szabó Z, Bogár L, Károlyi M, Gartner B, Kiss K, Havas A, Futó J. Eur J Anaesthesiol; 2010 Sep; 27(9):794-800. PubMed ID: 20520555 [Abstract] [Full Text] [Related]
34. Influence of a new hydroxyethylstarch preparation (HES 130/0.4) on coagulation in cardiac surgical patients. Haisch G, Boldt J, Krebs C, Suttner S, Lehmann A, Isgro F. J Cardiothorac Vasc Anesth; 2001 Jun; 15(3):316-21. PubMed ID: 11426361 [Abstract] [Full Text] [Related]
35. In cardiac surgery patients does Voluven(R) impair coagulation less than other colloids? Raja SG, Akhtar S, Shahbaz Y, Masood A. Interact Cardiovasc Thorac Surg; 2011 Jun; 12(6):1022-7. PubMed ID: 21398650 [Abstract] [Full Text] [Related]
36. Replacement of major surgical blood loss by hypo-oncotic or conventional plasma substitutes. Hiippala S, Linko K, Myllylä G, Lalla M, Hekali R, Mäkeläinen A. Acta Anaesthesiol Scand; 1995 Feb; 39(2):228-35. PubMed ID: 7540789 [Abstract] [Full Text] [Related]
37. Effects of 6% hydroxyethyl starch and 3% modified fluid gelatin on intravascular volume and coagulation during intraoperative hemodilution. Mortelmans YJ, Vermaut G, Verbruggen AM, Arnout JM, Vermylen J, Van Aken H, Mortelmans LA. Anesth Analg; 1995 Dec; 81(6):1235-42. PubMed ID: 7486110 [Abstract] [Full Text] [Related]
39. Plasma substitution effects of a new hydroxyethyl starch HES 130/0.4 compared with HES 200/0.5 during and after extended acute normovolaemic haemodilution. Ickx BE, Bepperling F, Melot C, Schulman C, Van der Linden PJ. Br J Anaesth; 2003 Aug; 91(2):196-202. PubMed ID: 12878617 [Abstract] [Full Text] [Related]
40. Colloids versus crystalloids and tissue oxygen tension in patients undergoing major abdominal surgery. Lang K, Boldt J, Suttner S, Haisch G. Anesth Analg; 2001 Aug; 93(2):405-9 , 3rd contents page. PubMed ID: 11473870 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]